Underlying scientific evidence discovery for FDA orphan drug designations from the GARD integrative knowledge graph: Towards drug discovery for rare diseases

被引:0
|
作者
Zhu, Qian [1 ]
Dac-Trung Nguyen [1 ]
Southall, Noel [1 ]
机构
[1] NIH, NCATS, Rockville, MD USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
110
引用
收藏
页数:1
相关论文
共 15 条
  • [1] An integrative knowledge graph for rare diseases, derived from the Genetic and Rare Diseases Information Center (GARD)
    Qian Zhu
    Dac-Trung Nguyen
    Ivan Grishagin
    Noel Southall
    Eric Sid
    Anne Pariser
    Journal of Biomedical Semantics, 11
  • [2] An integrative knowledge graph for rare diseases, derived from the Genetic and Rare Diseases Information Center (GARD)
    Zhu, Qian
    Nguyen, Dac-Trung
    Grishagin, Ivan
    Southall, Noel
    Sid, Eric
    Pariser, Anne
    JOURNAL OF BIOMEDICAL SEMANTICS, 2020, 11 (01)
  • [3] Knowledge-based approaches to drug discovery for rare diseases
    Alves, Vinicius M.
    Korn, Daniel
    Pervitsky, Vera
    Thieme, Andrew
    Capuzzi, Stephen J.
    Baker, Nancy
    Chirkova, Rada
    Ekins, Sean
    Muratov, Eugene N.
    Hickey, Anthony
    Tropsha, Alexander
    DRUG DISCOVERY TODAY, 2022, 27 (02) : 490 - 502
  • [4] RDKG-115: Assisting drug repurposing and discovery for rare diseases by trimodal knowledge graph embedding
    Zhu, Chaoyu
    Xia, Xiaoqiong
    Li, Nan
    Zhong, Fan
    Yang, Zhihao
    Liu, Lei
    COMPUTERS IN BIOLOGY AND MEDICINE, 2023, 164
  • [5] Scientific evidence based rare disease research discovery with research funding data in knowledge graph
    Qian Zhu
    Ðắc-Trung Nguyễn
    Timothy Sheils
    Gioconda Alyea
    Eric Sid
    Yanji Xu
    James Dickens
    Ewy A. Mathé
    Anne Pariser
    Orphanet Journal of Rare Diseases, 16
  • [6] Scientific evidence based rare disease research discovery with research funding data in knowledge graph
    Zhu, Qian
    Dac-Trung Nguyen
    Sheils, Timothy
    Alyea, Gioconda
    Sid, Eric
    Xu, Yanji
    Dickens, James
    Mathe, Ewy A.
    Pariser, Anne
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [7] Data-driven drug discovery for rare diseases: tales from the trenches
    van den Broek, Frederik
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [8] GrEDeL: A Knowledge Graph Embedding Based Method for Drug Discovery From Biomedical Literatures
    Sang, Shengtian
    Yang, Zhihao
    Liu, Xiaoxia
    Wang, Lei
    Lin, Hongfei
    Wang, Jian
    Dumontier, Michel
    IEEE ACCESS, 2019, 7 : 8404 - 8415
  • [9] Knowledge-augmented Graph Machine Learning for Drug Discovery: From Precision to Interpretability
    Zhong, Zhiqiang
    Mottin, Davide
    PROCEEDINGS OF THE 29TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, KDD 2023, 2023, : 5841 - 5842
  • [10] Using four decades of FDA orphan drug designations to describe trends in rare disease drug development: substantial growth seen in development of drugs for rare oncologic, neurologic, and pediatric-onset diseases
    Kathleen L. Miller
    Lewis J. Fermaglich
    Janet Maynard
    Orphanet Journal of Rare Diseases, 16